Priority Date: 14.06.06 (US 20060813903P)

Methods for the treatment of autoimmune disorders using monoclonal antibodies with reduced toxicity

  • Application ID: EP14166617
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Attorney

operating since 1887
Headquarter in London and 18 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 233 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 14.06.2006 - Priority Date (US 20060813903P)
  • 24.12.2014 - Publication A1 (EP2815764)